$BBWI

Bath & Body Works, Inc.

Bath & Body Works sells body care, home fragrance, soap and sanitizer products to consumers. Its products include fine fragrance mist, body cream, lotion, eau de parfum, body wash, hand soap, sanitizer and 3-wick candles. The company sells through company-operated stores and e-commerce sites in the U.S. and Canada, partner-operated stores and e-commerce sites in more than 45 other countries, and Amazon. It earns money from product sales through its retail and online channels and through franchise, license and wholesale arrangements with international partners. As of January 31, 2026, it operates 1,927 stores in the U.S. and Canada, while partners operate 573 international stores. Bath & Body Works is headquartered in Columbus, Ohio.

1
4
1

No SEC Form 4 filings for $BBWI in the last 30 days.

See all $BBWI insider activity →
Med

Bath & Body Works earnings up next amid turnaround test

Bath & Body Works (BBWI) will report Q3 earnings on November 19, 2026. Analysts expect EPS of $0.12 on revenue of $1.55B, down 66% and 3% YoY, respectively. The company's 'Consumer First Formula' strategy is under scrutiny. Analysts have a Hold rating and a mean price target of $24.93. Investors will watch for sales stabilization and Q4 guidance.

BBWI Q3'26 Earnings: EPS estimate is 0.12 USD

BBWI is scheduled to release Q3'26 earnings on November 19, with expected revenue of $1.55 billion and EPS of $0.12. The announcement is set for 6:55 AM ET.

Why Bath & Body Works Is Dropping 6.7%: UBS Maintains Neutral

Bath & Body Works' stock fell 6.7% to $19.95 on Monday, despite UBS raising its price target to $22 (up from $17) while maintaining a Neutral rating. The company's shares traded at 2.5M, reflecting investor caution amid broader retail sector challenges, despite the analyst's optimism.

BBWI sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 6 news stories mentioning BBWI (Bath & Body Works, Inc.). Coverage has been balanced: 1 bullish, 4 neutral, and 1 bearish.

Recent BBWI coverage spans earnings, financial news and market movers.

What's driving BBWI

AlphAI scores every news story that mentions BBWI with an AI model for sentiment and relevance, and aggregates insider trades from Bath & Body Works, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $BBWI

Score

Bath & Body Works earnings up next amid turnaround test

Bath & Body Works (BBWI) will report Q3 earnings on November 19, 2026. Analysts expect EPS of $0.12 on revenue of $1.55B, down 66% and 3% YoY, respectively. The company's 'Consumer First Formula' strategy is under scrutiny. Analysts have a Hold rating and a mean price target of $24.93. Investors will watch for sales stabilization and Q4 guidance.

Bath & Body Works Tests New Stores as U.S. and Canadian Store Sales Fall

Bath & Body Works opened two test 'Feel Good' stores amid a 5.4% quarterly sales decline in U.S. and Canadian stores. The stores feature scent-based layouts and digital tools. Q2 sales fell to $1.514 billion, with direct sales up 3%. CEO Daniel Heaf reported initial positive sales in Charlotte. The company plans to study shopper response and has not announced a broader rollout. Earnings are due Nov. 19.

Spotting winners: Bath and Body Works (NYSE:BBWI) and beauty and cosmetics retailer stocks in Q2

Bath & Body Works (BBWI) reported Q2 revenue of $1.51B, down 2.3% YoY, beating estimates by 1.2%. EPS beat but missed guidance. Stock up 14.9%. Ulta (ULTA) reported $3.04B revenue, up 8.9% YoY, beating estimates. Stock up 11.6%. Sally Beauty (SBH) reported flat revenue, in line with estimates. Stock up 10.6%. Warby Parker (WRBY) reported $235.5M revenue, up 9.8% YoY, missing estimates by 1%. Stock down 12.7%.

Bath & Body Works makes a big move for the holidays

Bath & Body Works is expanding its partnership with Ulta Beauty for the holidays, introducing exclusive products like the discontinued Pink Suede fragrance. This move is part of a strategy to reach customers beyond its own stores, as the company faces a 5.4% decline in in-store sales. Deloitte expects holiday spending to rise 4% to $1,654 per household.

Bath & Body Works faces surprising problem as Americans return to malls

Bath & Body Works reports a 5.4% decline in U.S. and Canadian store sales in Q2 2026, despite a 5% increase in mall visits. The company plans to shift 75% of stores outside malls, citing better performance in off-mall locations. Direct sales grew by 3%, while international sales increased by 24.9%. The retailer aims to improve store navigation and expand distribution through Amazon and Ulta Beauty.

Related tickers